抗肿瘤坏死因子-α治疗后未确诊皮肤淋巴瘤的进展
多中心回顾性研究及文献复习分析抗肿瘤坏死因子-α(anti-TNF-α)治疗期间或之后诊断的皮肤淋巴瘤22例,其中20例为皮肤T细胞淋巴瘤(CTCL),2例为皮肤B细胞淋巴瘤。CTCL组75%的患者因疑似炎症性皮肤病接受anti-TNF-α治疗,诊断时常见晚期疾病(IIB至IVA期)并需积极治疗,包括3例干细胞移植。文献检索另汇集31例。作者认为多数患者疾病被误诊为银屑病或湿疹,建议在开始anti-TNF-α治疗前对界定不清的皮炎或不典型银屑病表现考虑进行全面形态学和分子学复查。
要点
- 22例中20例为CTCL,2例为皮肤B细胞淋巴瘤,后者病程惰性。
- CTCL组75%因疑似炎症性皮肤病接受anti-TNF-α治疗。
- 诊断时常见晚期(IIB至IVA期),3例需干细胞移植。
核心结论
- 作者认为多数 identified 患者的疾病被误诊为银屑病或湿疹,建议在开始anti-TNF-α治疗前对界定不清的皮炎或不典型银屑病表现考虑全面形态学和分子学复查皮肤活检标本及外周血样本。
研究设计与样本
- 多中心回顾性研究及文献复习,共识别22例(20例CTCL,2例皮肤B细胞淋巴瘤),文献检索汇集31例。
主要发现
- CTCL组75%的患者因疑似炎症性皮肤病接受anti-TNF-α治疗。
- CTCL诊断时常见晚期疾病(IIB至IVA期),需积极治疗,包括3例干细胞移植。
- 2例皮肤B细胞淋巴瘤患者病程惰性。
临床怎么用
- 作者建议在开始anti-TNF-α治疗前,对界定不清的皮炎或不典型银屑病表现考虑全面形态学和分子学复查皮肤活检标本及外周血样本。
局限性
- 本研究为回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cutaneous lymphoma diagnosed after anti-tumor necrosis factor-α therapy (anti-TNF-α) has been reported in the literature, yet a clear link between both events remains elusive. OBJECTIVE: To review our experience with cutaneous lymphoma diagnosed during or after the use of anti-TNF-α therapies. METHODS: This is a multicenter retrospective study and a literature review. RESULTS: A total of 22 cases, including 20 cutaneous T-cell lymphomas (CTCLs) and 2 cutaneous B-cell lymphomas, were identified. In the CTCL group, 75% of the patients received an anti-TNF-α agent for a presumed inflammatory skin condition. Mycosis fungoides and Sézary syndrome were the most common subtypes of CTCL diagnosed. Advanced disease (stage IIB to IVA) was commonly seen at time of diagnosis and required aggressive therapy, including stem cell transplant in 3 patients; 2 patients in whom cutaneous B-cell lymphomas was diagnosed had an indolent course. A total of 31 cases were gathered from a literature search. LIMITATIONS: This is a retrospective study. CONCLUSIONS: Our findings suggest that the disease of most of the identified patients was misdiagnosed as psoriasis or eczema; therefore, a comprehensive morphologic and molecular review of skin biopsy specimens and peripheral blood samples should be considered before initiation of anti-TNF-α therapy in patients with poorly defined dermatitis or atypical presentations of psoriasis.
引用
- Martinez-Escala ME, Posligua AL, Wickless H, et al. Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor-alpha therapy. J Am Acad Dermatol. 2018. PMID: 29307643. doi:10.1016/j.jaad.2017.12.068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。